CapsulesClinical Overview
Pancreatin Gastro-Resistant Capsules (10,000, 25,000, 40,000 Lipase Units) is an oral porcine pancreatic enzyme replacement therapy (PERT) on the WHO Model List of Essential Medicines. Each capsule contains enteric-coated mini-microspheres designed to withstand gastric acid and dissolve rapidly at duodenal pH > 5.5, releasing standardized concentrations of lipase, amylase, and protease for physiological digestion of lipids, carbohydrates, and proteins. Indicated for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis, chronic pancreatitis, pancreatectomy, and gastrectomy.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with every meal and snack with ample fluid. Swallow whole; do not crush or chew microspheres. For patients unable to swallow capsules, open and mix the intact microspheres with acidic soft food (applesauce, yogurt, pH < 5.5) and consume immediately without chewing. Dosage is individualized based on clinical symptoms and fecal fat content.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Abdominal discomfort, flatulence, constipation, nausea, diarrhea. Rare/Severe: Fibrosing colonopathy (colonic strictures) reported with very high doses (>10,000 lipase units/kg/day) in cystic fibrosis children, and hyperuricemia.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Do not crush or chew microspheres (destroys enteric coating and can cause severe oral ulceration). Porcine origin; caution in porcine protein hypersensitivity. Monitor for fibrosing colonopathy if daily dose exceeds 10,000 lipase units/kg/day.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Pancreatin 170mg + Activated Dimethicone 80mg Tablets
Pancreatin (170mg) with Bile Salts (Sodium Tauroglycocholate 65mg) and/or Dimethicone (80mg) Tablets is a comprehensive digestive enzyme and emulsifying formulation. Pancreatin provides amylase, lipase, and protease; tauroglycocholate emulsifies dietary fats and activates pancreatic lipase for optimal absorption; dimethicone reduces surface tension of trapped gas bubbles. Indicated for exocrine pancreatic insufficiency, chronic pancreatitis, dyspepsia, fatty food intolerance, and flatulent indigestion.
Pancreatin 170 mg (containing 15000 units of Amylase activity + 4000 units of Lipase activity + 15000 units of Protease activity) + Sodium Tauroglycocholate 65mg Digestive Enzyme Tablets
Pancreatin (170mg) with Bile Salts (Sodium Tauroglycocholate 65mg) and/or Dimethicone (80mg) Tablets is a comprehensive digestive enzyme and emulsifying formulation. Pancreatin provides amylase, lipase, and protease; tauroglycocholate emulsifies dietary fats and activates pancreatic lipase for optimal absorption; dimethicone reduces surface tension of trapped gas bubbles. Indicated for exocrine pancreatic insufficiency, chronic pancreatitis, dyspepsia, fatty food intolerance, and flatulent indigestion.
L-Ornithine L-Aspartate 150mg + Pancreatin 100mg Tablets
L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.
Pancreatin Capsules 25000
Pancreatin Gastro-Resistant Capsules (10,000, 25,000, 40,000 Lipase Units) is an oral porcine pancreatic enzyme replacement therapy (PERT) on the WHO Model List of Essential Medicines. Each capsule contains enteric-coated mini-microspheres designed to withstand gastric acid and dissolve rapidly at duodenal pH > 5.5, releasing standardized concentrations of lipase, amylase, and protease for physiological digestion of lipids, carbohydrates, and proteins. Indicated for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis, chronic pancreatitis, pancreatectomy, and gastrectomy.